Sobera Capital
Est. dry powder
—
Not reported
AUM
$58.8M
Assets under management
Latest fund
$5.3M
medTECH Capital Fonds
Est. cheque size
$217.4K–
From fund sizes
Deals, last 12 months
—
Not reported
About Sobera Capital
Sobera Capital is a Germany-based private equity firm specialized in secondary directs, limited partnership secondaries and secondary management, with a focus on growth and small-cap companies in ICT, healthcare, and other industries across Europe, Western Europe, the UK, and the US.
- Type
- Private Equity Firm
- Headquarters
- Berlin, Germany
- Stages
- Secondaries
- Est. cheque size
- $217.4K–$2.7M
- Sectors
- Healthcare, Energy & Utilities, Diversified
- Regions
- Europe
- Strategies
- Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- —3
- Secondary Stock Purchase2
- Growth Capital/Expansion1
Across 7 deals
Portfolio sectors
- Medical Devices & Equipment2
- Healthcare1
- Materials1
- Pharmaceuticals1
- Software1
Across 6 companies
Portfolio countries
- Germany2
- US2
- France1
- UK1
Across 6 companies
Recent investments
Newest 5 of 7
- ——
SONOMO
Apr 2020 · —
- Secondary Stock Purchase—
Presidio Pharmaceuticals Inc.
Feb 2018 · Secondary Stock Purchase
- Secondary Stock Purchase—
Myoscience, Inc.
Feb 2018 · Secondary Stock Purchase
- ——
More Medical Solutions GmbH
Feb 2016 · —
- ——
Axellis Ventures
Feb 2016 · —
Offices
2 locations
- Berlin, GermanyHQ
- Regensburg, Germany
Questions about Sobera Capital
How much does Sobera Capital invest per deal?
Based on the size of its funds, Sobera Capital writes estimated cheques of $217.4K–$2.7M. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does Sobera Capital invest in?
Sobera Capital has invested at Secondaries. Its most frequent rounds on record are —, Secondary Stock Purchase and Growth Capital/Expansion.
What has Sobera Capital invested in recently?
Recent investments include SONOMO, Presidio Pharmaceuticals Inc. and Myoscience, Inc..